Testing Vibration Added to Robotic Walking Training After Stroke
Tests whether vibration added to robotic gait training helps adults recovering from stroke walk better.
Plain-language title generated from the registry record
Registry title: The Potential of Robotic-Assisted Gait Training in a Rehabilitation Setting
Key facts
- Where
- Gröbming, AustriaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT07529054, who can take part
Where in Austria
- Reha-Zentrum GröbmingGröbming, AustriaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ludwig Boltzmann Institute for Arthritis and Rehabilitation
- Trial code
- NCT07529054
- Record updated
- 14 April 2026
- Original description
Robotic-assisted gait training (RAGT) devices, such as the Lokomat®, are commonly used to support gait rehabilitation by enabling repetitive, task-specific walking movements. The functional proprioceptive stimulation (FPS) device Vibramoov® represents a novel technology designed to stimulate proprioceptors at the muscle-tendon junction through targeted vibratory stimuli, thereby activating sensorimotor centers in the brain and potentially facilitating movement execution.Read full original descriptionShow less
The Potential of Robotic-Assisted Gait Training in a Rehabilitation Settin
Robotic-assisted gait training (RAGT) devices, such as the Lokomat®, are commonly used to support gait rehabilitation by enabling repetitive, task-specific walking movements. The functional proprioceptive stimulation (FPS) device Vibramoov® represents a novel technology designed to stimulate proprioceptors at the muscle-tendon junction through targeted vibratory stimuli, thereby activating sensorimotor centers in the brain and potentially facilitating movement execution.
The aim of this randomized controlled trial is to investigate whether Lokomat® training combined with Vibramoov® leads to greater improvements in qualitative and quantitative gait parameters in stroke patients compared with Lokomat® training alone. The study will be conducted at the Gröbming Rehabilitation Center and will include patients undergoing a four-week neurological inpatient rehabilitation program. Participants will be randomly assigned to an intervention group (Lokomat® + Vibramoov®) or a control group (Lokomat® only), with 20 patients per group.
Primary outcomes include the 6-Minute Walk Test (6MWT) and spatiotemporal gait parameters. Additional assessments include functional scores, patient-reported outcome measures, and blood biomarkers. Statistical analyses will be performed depending on data distribution. A follow-up assessment evaluating EQ-5D and PHQ-4 will be conducted six months after completion of the rehabilitation program.
Inclusion: Diagnosis of stroke (ischemic or hemorrhagic) ≥ 3 months; Age ≥ 18a and ≤ 80a; 6MWT ≤ 200m; Barthel Index ≤ 95; Mini Mental State Exam (MMSE) ≥ 24; FAC: ≤ 4; BBS): ≤49; Modified Ashworth Scale (MAS): 0-3 for the lower extremity.
Exclusion: The presence of any comorbidity or disability other than stroke that would preclude gait training; Any uncontrolled health condition for which exercise is contraindicated.